These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23720766)

  • 1. Pharmacologic activation of PKM2 slows lung tumor xenograft growth.
    Parnell KM; Foulks JM; Nix RN; Clifford A; Bullough J; Luo B; Senina A; Vollmer D; Liu J; McCarthy V; Xu Y; Saunders M; Liu XH; Pearce S; Wright K; O'Reilly M; McCullar MV; Ho KK; Kanner SB
    Mol Cancer Ther; 2013 Aug; 12(8):1453-60. PubMed ID: 23720766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2).
    Xu Y; Liu XH; Saunders M; Pearce S; Foulks JM; Parnell KM; Clifford A; Nix RN; Bullough J; Hendrickson TF; Wright K; McCullar MV; Kanner SB; Ho KK
    Bioorg Med Chem Lett; 2014 Jan; 24(2):515-9. PubMed ID: 24374270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel 7-azaindole derivatives containing pyridin-3-ylmethyl dithiocarbamate moiety as potent PKM2 activators and PKM2 nucleus translocation inhibitors.
    Liu B; Yuan X; Xu B; Zhang H; Li R; Wang X; Ge Z; Li R
    Eur J Med Chem; 2019 May; 170():1-15. PubMed ID: 30878825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKM2 Thr454 phosphorylation increases its nuclear translocation and promotes xenograft tumor growth in A549 human lung cancer cells.
    Yu Z; Huang L; Qiao P; Jiang A; Wang L; Yang T; Tang S; Zhang W; Ren C
    Biochem Biophys Res Commun; 2016 May; 473(4):953-958. PubMed ID: 27045080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activators of PKM2 in cancer metabolism.
    Warner SL; Carpenter KJ; Bearss DJ
    Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.
    Yacovan A; Ozeri R; Kehat T; Mirilashvili S; Sherman D; Aizikovich A; Shitrit A; Ben-Zeev E; Schutz N; Bohana-Kashtan O; Konson A; Behar V; Becker OM
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6460-8. PubMed ID: 22963766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2.
    Xiao M; Xie J; Wu Y; Wang G; Qi X; Liu Z; Wang Y; Wang X; Hoque A; Oakhill J; Proud CG; Li J
    Cell Commun Signal; 2020 Feb; 18(1):25. PubMed ID: 32054489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 2-((1H-benzo[d]imidazol-1-yl)methyl)-4H-pyrido[1,2-a]pyrimidin-4-ones as novel PKM2 activators.
    Guo C; Linton A; Jalaie M; Kephart S; Ornelas M; Pairish M; Greasley S; Richardson P; Maegley K; Hickey M; Li J; Wu X; Ji X; Xie Z
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3358-63. PubMed ID: 23622982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma.
    Sun H; Zhu A; Zhang L; Zhang J; Zhong Z; Wang F
    Int J Mol Sci; 2015 Oct; 16(10):24574-87. PubMed ID: 26501265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analyses of the cysteine thiol oxidation of PKM2 reveal the effects of multiple oxidation on cellular oxidative stress response.
    Irokawa H; Numasaki S; Kato S; Iwai K; Inose-Maruyama A; Ohdate T; Hwang GW; Toyama T; Watanabe T; Kuge S
    Biochem J; 2021 Apr; 478(7):1453-1470. PubMed ID: 33749780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting pyruvate kinase muscle isoform 2 (PKM2) in cancer: What do we know so far?
    Chhipa AS; Patel S
    Life Sci; 2021 Sep; 280():119694. PubMed ID: 34102192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and structure-activity relationship of novel 4-hydroxy-thiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activators.
    Li R; Ning X; Zhou S; Lin Z; Wu X; Chen H; Bai X; Wang X; Ge Z; Li R; Yin Y
    Eur J Med Chem; 2018 Jan; 143():48-65. PubMed ID: 29172082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Product Micheliolide (MCL) Irreversibly Activates Pyruvate Kinase M2 and Suppresses Leukemia.
    Li J; Li S; Guo J; Li Q; Long J; Ma C; Ding Y; Yan C; Li L; Wu Z; Zhu H; Li KK; Wen L; Zhang Q; Xue Q; Zhao C; Liu N; Ivanov I; Luo M; Xi R; Long H; Wang PG; Chen Y
    J Med Chem; 2018 May; 61(9):4155-4164. PubMed ID: 29641204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RACK1 forms a complex with FGFR1 and PKM2, and stimulates the growth and migration of squamous lung cancer cells.
    Zhou C; Chen T; Xie Z; Qin Y; Ou Y; Zhang J; Li S; Chen R; Zhong N
    Mol Carcinog; 2017 Nov; 56(11):2391-2399. PubMed ID: 28418088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation.
    Azoitei N; Becher A; Steinestel K; Rouhi A; Diepold K; Genze F; Simmet T; Seufferlein T
    Mol Cancer; 2016 Jan; 15():3. PubMed ID: 26739387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma.
    Guo CY; Zhu Q; Tou FF; Wen XM; Kuang YK; Hu H
    BMC Cancer; 2019 Mar; 19(1):289. PubMed ID: 30925904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate kinase isozyme M2 and glutaminase might be promising molecular targets for the treatment of gastric cancer.
    Kitayama K; Yashiro M; Morisaki T; Miki Y; Okuno T; Kinoshita H; Fukuoka T; Kasashima H; Masuda G; Hasegawa T; Sakurai K; Kubo N; Hirakawa K; Ohira M
    Cancer Sci; 2017 Dec; 108(12):2462-2469. PubMed ID: 29032577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of boronic acid-based potent activators of tumor pyruvate kinase M2 and development of gastroretentive nanoformulation for oral dosing.
    Patle R; Shinde S; Patel S; Maheshwari R; Jariyal H; Srivastava A; Chauhan N; Globisch C; Jain A; Tekade RK; Shard A
    Bioorg Med Chem Lett; 2021 Jun; 42():128062. PubMed ID: 33901643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
    Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
    Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.